Ramipril May Lower End-Stage Renal Disease Risk in Obese - Doctors Lounge PDF Print
Doctors Lounge
Ramipril may reduce the risk of end-stage renal disease in obese patients with non-diabetic chronic kidney disease, according to a study published online April 28 in the Journal of the American Society of Nephrology. FRIDAY, April 29 (HealthDay News)

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.